This study highlights the role of psychological influences in triggering and amplifying the adverse effects of the COVID-19 vaccine (i.e., nocebo effects). Fear, beliefs, and expectations about the COVID-19 vaccine, trust in health and scientific institutions, and stable personality traits were measured in 315 adult Italian citizens (145 men) during the 15-min waiting time after vaccination. The occurrence and severity of 10 potential adverse effects were assessed 24 hr later. Nonpharmacological variables predicted nearly 30% of the severity of the vaccine’s adverse effects. Expectations are important determinants of adverse effects from vaccines, and the results of the path analyses show that these expectations stem primarily from people’s vaccine beliefs and attitudes, which can be changed. Implications for increasing vaccine acceptability and limiting the nocebo effect are discussed.
AmanzioM.MitsikostasD. D.GiovannelliF.BartoliM.CiprianiG. E.BrownW. A. (2022). Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review. The Lancet Regional Health - Europe, 12, Article 100253. https://doi.org/10.1016/j.lanepe.2021.100253
2.
AtlasL. Y. (2021). A social affective neuroscience lens on placebo analgesia. Trends in Cognitive Sciences, 25(11), 992–1005. https://doi.org/10.1016/j.tics.2021.07.016
3.
BajcarE. A.Wiercioch-KuzianikK.FarleyD.BuglewiczE.PaulewiczB.BąbelP. (2021). Order does matter: The combined effects of classical conditioning and verbal suggestions on placebo hypoalgesia and nocebo hyperalgesia. Pain, 162(8), 2237–2245. https://doi.org/10.1097/j.pain.0000000000002211
BetschC.SachseK. (2013). Debunking vaccination myths: Strong risk negations can increase perceived vaccination risks. Health Psychology, 32(2), 146–155. https://doi.org/10.1037/a0027387
6.
BingelU. (for the Placebo Competence Team). (2014). Avoiding nocebo effects to optimize treatment outcome. Journal of the American Medical Association, 312(7), 693–694. https://doi.org/10.1001/JAMA.2014.8342
7.
BlasiniM.CorsiN.KlingerR.CollocaL. (2017). Nocebo and pain: An overview of the psychoneurobiological mechanisms. Pain Reports, 2(2), Article e585. https://doi.org/10.1097/PR9.0000000000000585
DevlinE. J.WhitfordH. S.PeoplesA. R.MorrowG. R.KatragaddaS.GiguereJ. K.NaqviB.RoscoeJ. (2021). Psychological predictors of chemotherapy-induced nausea in women with breast cancer: Expectancies and perceived susceptibility. European Journal of Cancer Care, 30(6), Article e13488. https://doi.org/10.1111/ecc.13488
GeersA. L.ClemensK. S.FaasseK.ColagiuriB.WebsterR.VaseL.SiegM.JasonE.CollocaL. (2022). Psychosocial factors predict COVID-19 vaccine side effects. Psychotherapy and Psychosomatics, 91, 136–138. https://doi.org/10.1159/000519853
14.
GoldenbergM. J. (2016). Public misunderstanding of science? Reframing the problem of vaccine hesitancy. Perspectives on Science, 24(5), 552–581. https://doi.org/10.1162/POSC_a_00223
15.
HaasJ. W.BenderF. L.BallouS.KelleyJ. M.WilhelmM.MillerF. G.RiefW.KaptchukT. J. (2022). Frequency of adverse events in the placebo arms of COVID-19 vaccine trials: A systematic review and meta-analysis. JAMA Network Open, 5(1), Article e2143955. https://doi.org/10.1001/JAMANETWORKOPEN.2021.43955
16.
HorneZ.PowellD.HummelJ. E.HolyoakK. J. (2015). Countering antivaccination attitudes. Proceedings of the National Academy of Sciences, USA, 112(33), 10321–10324. https://doi.org/10.1073/pnas.1504019112
17.
HornseyM. J.HarrisE. A.FieldingK. S. (2018). The psychological roots of anti-vaccination attitudes: A 24-nation investigation. Health Psychology, 37(4), 307–315. https://doi.org/10.1037/hea0000586.supp
18.
HuL.-T.BentlerP. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55. https://doi.org/10.1080/10705519909540118
19.
JacksonL. A.AndersonE. J.RouphaelN. G.RobertsP. C.MakheneM.ColerR. N.McCulloughM. P.ChappellJ. D.DenisonM. R.StevensL. J.PruijssersA. J.McDermottA.FlachB.Doria-RoseN. A.CorbettK. S.MorabitoK. M.O’DellS.SchmidtS. D.SwansonP. A.. . . BeigelJ. H. (2020). An mRNA vaccine against SARS-CoV-2—Preliminary report. New England Journal of Medicine, 383(20), 1920–1931. https://doi.org/10.1056/nejmoa2022483
20.
JensenK. B.KaptchukT. J.KirschI.RaicekJ.LindstromK. M.BernaC.GollubR. L.IngvarM.KongJ. (2012). Nonconscious activation of placebo and nocebo pain responses. Proceedings of the National Academy of Sciences, USA, 109(39), 15959–15964. https://doi.org/10.1073/pnas.1202056109
KlugarM.RiadA.MekhemarM.ConradJ.BuchbenderM.HowaldtH. P.AttiaS. (2021). Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology, 10(8), Article 752. https://doi.org/10.3390/biology10080752
23.
KraussB. S. (2015). “This may hurt:” Predictions in procedural disclosure may do harm. The BMJ, 350, Article h649. https://doi.org/10.1136/bmj.h649
24.
LarsonH. J.JarrettC.EckersbergerE.SmithD. M. D.PatersonP. (2014). Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine, 32(19), 2150–2159. https://doi.org/10.1016/j.vaccine.2014.01.081
25.
Levine-TiefenbrunM.YelinI.KatzR.HerzelE.GolanZ.SchreiberL.WolfT.NadlerV.Ben-TovA.KuintJ.GazitS.PatalonT.ChodickG.KishonyR. (2021). Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nature Medicine, 27(5), 790–792. https://doi.org/10.1038/s41591-021-01316-7
MorleyG. L.TaylorS.JossiS.Perez-ToledoM.FaustiniS. E.Marcial-JuarezE.ShieldsA. M.GoodallM.AllenJ. D.WatanabeY.NewbyM. L.CrispinM.DraysonM. T.CunninghamA. F.RichterA. G.O’SheaM. K. (2020). Sensitive detection of SARS-CoV-2-Specific antibodies in dried blood spot samples. Emerging Infectious Diseases, 26(12), 2970–2973. https://doi.org/10.3201/EID2612.203309
29.
PatersonP.MeuriceF.StanberryL. R.GlismannS.RosenthalS. L.LarsonH. J. (2016). Vaccine hesitancy and healthcare providers. Vaccine, 34(52), 6700–6706. https://doi.org/10.1016/j.vaccine.2016.10.042
30.
PennycookG.McPhetresJ.ZhangY.LuJ. G.RandD. G. (2020). Fighting COVID-19 misinformation on social media: Experimental evidence for a scalable accuracy-nudge intervention. Psychological Science, 31(7), 770–780. https://doi.org/10.1177/0956797620939054
31.
RenoC.MaiettiE.FantiniM. P.SavoiaE.ManzoliL.MontaltiM.GoriD. (2021). Enhancing COVID-19 vaccines acceptance: Results from a survey on vaccine hesitancy in northern Italy. Vaccines, 9(4), Article 378. https://doi.org/10.3390/vaccines9040378
32.
RiadA.SağıroğluD.ÜstünB.PokornáA.KlugarováJ.AttiaS.KlugarM. (2021). Prevalence and risk factors of CoronaVac side effects: An independent cross-sectional study among healthcare workers in Turkey. Journal of Clinical Medicine, 10(12), Article 2629. https://doi.org/10.3390/jcm10122629
33.
RiefW. (2021). Fear of adverse effects and COVID-19 vaccine hesitancy: Recommendations of the treatment expectation expert group. JAMA Health Forum, 2(4), Article e210804. https://doi.org/10.1001/JAMAHEALTHFORUM.2021.0804
34.
RiefW.AvornJ.BarskyA. J. (2006). Medication-attributed adverse effects in placebo groups: Implications for assessment of adverse effects. Archives of Internal Medicine, 166(2), 155–160. https://doi.org/10.1001/archinte.166.2.155
35.
SadeghalvadM.MansourabadiA. H.NooriM.NejadghaderiS. A.MasoomikarimiM.AlimohammadiM.RezaeiN. (2022). Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies. Reviews in Medical Virology, 33, Article e2359. https://doi.org/10.1002/rmv.2359
36.
SchwarzingerM.WatsonV.ArwidsonP.AllaF.LuchiniS. (2021). COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. The Lancet Public Health, 6(4), e210–e221. https://doi.org/10.1016/S2468-2667(21)00012-8
37.
SmithL. E.SimJ.AmlôtR.CuttsM.DaschH.SevdalisN.RubinG. J.ShermanS. M. (2022). Side-effect expectations from COVID-19 vaccination: Findings from a nationally representative cross-sectional survey (CoVAccS – wave 2). Journal of Psychosomatic Research, 152, Article 110679. https://doi.org/10.1016/j.jpsychores.2021.110679
38.
SmithL. E.WebsterR. K.RubinG. J. (2020). A systematic review of factors associated with side-effect expectations from medical interventions. Health Expectations, 23(4), 731–758. https://doi.org/10.1111/hex.13059
39.
SullivanM. J. L.BishopS. R.PivikJ. (1995). The Pain Catastrophizing Scale: Development and validation. Psychological Assessment, 7(4), 524–532. https://doi.org/10.1037/1040-3590.7.4.524
40.
TurgeonC. T.SandersK. A.GrangerD.NettS. L.HilgartH.MaternD.TheelE. S. (2021). Detection of SARS-CoV-2 IgG antibodies in dried blood spots. Diagnostic Microbiology and Infectious Disease, 101(1), Article 115425. https://doi.org/10.1016/j.diagmicrobio.2021.115425
41.
WalshE. E.FrenckR. W.FalseyA. R.KitchinN.AbsalonJ.GurtmanA.LockhartS.NeuzilK.MulliganM. J.BaileyR.SwansonK. A.LiP.KouryK.KalinaW.CooperD.Fontes-GarfiasC.ShiP.-Y.TüreciÖ.TompkinsK. R.. . . GruberW. C. (2020). Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. New England Journal of Medicine, 383(25), 2439–2450. https://doi.org/10.1056/nejmoa2027906
42.
WebsterR. K.WeinmanJ.James RubinG. (2016). A systematic review of factors that contribute to nocebo effects. Health Psychology, 35(12), 1334–1355. https://doi.org/10.1037/hea0000416
43.
ZinnJ. O. (2008). Heading into the unknown: Everyday strategies for managing risk and uncertainty. Health, Risk & Society, 10(5), 439–450. https://doi.org/10.1080/13698570802380891
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
